Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28124929 | 0.82 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29077318 | 0.81 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27584937 | 0.81 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| Phosphine SCHEMBL21980905 | 0.81 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| Phosphine SCHEMBL18954422 | 0.80 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5170733 | 0.80 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1067539 | 0.78 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL303034 | 0.78 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL245554 | 0.78 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28299179 | 0.77 | CA12 (0.41) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260051498-A1 | Electrode for Lithium Secondary Battery and Method for Manufacturing the Same | LG CHEM, LTD. (KR) | 2026-02-19 | — | — | US | claimed |
| EP-3471831-B1 | ONE PART ACRYLIC NAIL FORMULATION | MYCONE DENTAL SUPPLY CO INC (US) | 2026-01-07 | — | — | EP | claimed |
| WO-2025078096-A1 | A THERMALLY DEBONDABLE PRIMER COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-04-17 | — | — | WO | claimed |
| EP-4538330-A1 | A THERMALLY DEBONDABLE PRIMER COMPOSITION | Henkel AG & Co. KGaA (DE) | 2025-04-16 | — | — | EP | claimed |
| EP-4478460-A1 | ELECTRODE FOR LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | LG Chem, Ltd. (KR) | 2024-12-18 | — | — | EP | claimed |
| EP-3596177-B1 | ODORLESS UV CURABLE MONOMER SOLUTION | MYCONE DENTAL SUPPLY COMPANY INC (US) | 2023-11-29 | — | — | EP | claimed |
| US-11512227-B2 | Adhesive sheet and adhesive material using the same | LMS CO., LTD. (KR) | 2022-11-29 | — | — | US | claimed |
| US-20200368137-A1 | Odorless UV Curable Monomer Solution | MYCONE DENTAL SUPPLY CO INC (US) | 2020-11-26 | — | — | US | claimed |
| CN-111826109-A | UV-curable two-component epoxy adhesive | 上海回天新材料有限公司 | 2020-10-27 | — | — | CN | claimed |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | MYCONE DENTAL SUPPLY CO INC (US) | 2019-05-02 | — | — | US | claimed |
| US-6460464-B1 | MONOFUNCTIONAL (METH)ACRYLATE; ANAEROBIC CURE-INDUCING COMPONENT; PHOTOINITATOR COMPONENT; AND PLASTICIZER COMPONENT | HENKEL LOCTITE CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-6451948-B1 | (METH)ACRYLATE COMPONENT; A THERMAL RESISTANCE-CONFERRING COMPONENT INCLUDING POLYMERIZABLE AROMATIC MATERIALS HAVING AT LEAST ONE CLAISEN REARRANGABLE FUNCTIONAL GROUP; AND (C) A RADICAL CURE-INDUCING COMPOSITION. | LOCTITE CORPORATION | 2002-09-17 | — | — | US | claimed |
| US-6433036-B1 | METALLOCENE AND PHOTOINITIATOR; EXPOSURE TO ELECTROMAGNETIC RADIATION | LOCTITE CORPORATION | 2002-08-13 | — | — | US | claimed |
| US-20020107349-A1 | RADICAL-CURABLE ADHESIVE COMPOSITIONS, REACTION PRODUCTS OF WHICH DEMONSTRATE SUPERIOR RESISTANCE TO THERMAL DEGRADATION | LOCTITE CORPORATION | 2002-08-08 | — | — | US | claimed |
| WO-2002049011-A1 | ADHESIVES FOR DVD BONDING | LOCTITE CORPORATION (US) | 2002-06-20 | — | — | WO | claimed |
| US-6342545-B1 | ADHESION AND HEAT RESISTANCE WITH FREE RADICAL CURING | LOCTITE CORPORATION | 2002-01-29 | — | — | US | claimed |
| US-6323253-B1 | ACRYLATED POLYSILOXANE, PHOTOINITIATOR AND MOISTURE CURABLE CATALYST | LOCTITE CORPORATION | 2001-11-27 | — | — | US | claimed |
| US-6150479-A | CURABLE ADHESIVES FOR HEAT RESISTANCE | LOCTITE CORPORATION (US) | 2000-11-21 | — | — | US | claimed |
| WO-2000040663-A1 | ADHESION PROMOTERS | LOCTITE (R & D) LIMITED (IE) | 2000-07-13 | — | — | WO | claimed |
| US-5922783-A | METALLOCENE, PHOTOINITIATOR, CYANOACRYLATE COMPONENT; REDUCED BLOOMING, CRAZING | LOCTITE CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368137-A1 | Odorless UV Curable Monomer Solution | ETF1, POLR1C, DPM1 | CA12 3620/4885CA1 3826/4885CA2 4515/4885 |
| US-20190125652-A1 | One Part Acrylic Nail Formulation | POLR1C, NACA, PIK3C3 | CA12 4776/4885CA1 4746/4885CA2 4774/4885 |
| US-20260051498-A1 | Electrode for Lithium Secondary Battery and Method for Manufacturing the Same | ILK, EPCAM, L1CAM | CA12 528/4885CA1 1240/4885CA2 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.